Research and innovation news

A world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.

Professor Daniel Brison, Consultant Embryologist within Research and Innovation at MFT shares his personal motivation for his research journey in this area.

Three commonly prescribed statins are best placed to lower all the ‘bad’ types of cholesterol and prevent cardiovascular disease in people with diabetes, according to a new meta-analysis

A patient at Manchester University NHS Foundation Trust, is the first person in Europe to trial a new treatment for long-term (chronic) wounds.

Greater Manchester residents are being encouraged to take part in a major genetics study designed to improve health outcomes for South Asian people.

Three budding MFT entrepreneurs have been awarded places on the prestigious NHS Clinical Entrepreneur Programme.

Two leading Manchester University NHS Foundation Trust (MFT) researchers have been appointed Senior Investigators by the National Institute for Health Research (NIHR).

The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.